Skip to content
  • Home
  • Signal News
  • Biopharma Digest
    • Market Access Intelligence
    • Rare Disease Gene Therapy
    • Oncology
  • Week in Review
    • GLP-1 Competitive Market
    • NeuroMarket Pulse
      • Neurology Regulatory Interactive Calendar
    • Manufacturing Intelligence
  • Contact

Pharminent

 Posted in M&A / Deals

Biocytogen and Sihuan partner to advance new therapeutics for weight loss

 April 2, 2026

Pharmaceutical Business Review

Under the agreement, Biocytogen’s fully human antibody discovery platform will be combined with Sihuan Pharmaceutical’s capabilities in drug development, manufacturing, and commercialisation.

M&A / DealsMetabolic & GLP-1Read full story

Post navigation

Threat of Trump’s pharma tariffs looms again →
← Merck KGaA acquires JSR chromatography business

Categories

© 2026 Pharminent. All rights reserved.

Design by ThemesDNA.com